The major virulence determinant of the rodent malaria parasite, Plasmodium yoelii, has remained unresolved since the discovery of the lethal line in the 1970s. As virulence in this parasite correlates with the ability to invade different types of erythrocytes, we evaluated the potential role of the parasite erythrocyte binding ligand, PyEBL. We found one amino acid substitution in a domain responsible for intracellular trafficking between the lethal and non-lethal parasite lines, and, furthermore, that the intracellular localization of PyEBL was distinct between these lines. Genetic modification showed that this substitution was responsible not only for PyEBL localization, but also the erythrocyte-type invasion preference of the parasite, and subsequently its virulence in mice. This previously unrecognized mechanism for altering an invasion phenotype indicates that subtle alterations of a malaria parasite ligand can dramatically affect host-pathogen interactions and malaria virulence.
Introduction
The rodent malaria parasite Plasmodium yoelii yoelii has been widely studied in order to understand the interactions between the malaria parasite and the host-cell (1) . The non-lethal 17X line mainly infects young erythrocytes (reticulocytes) whereas the lethal 17XL and YM lines infect a wide range of erythrocytes. These lines have previously been studied in order to identify the genetic determinants of virulence (2, 3) . These differences in erythrocyte invasion preference suggest the possible involvement of a parasite ligand that recognizes erythrocyte surface receptors, however, the actual molecular basis of the observed invasion preference differences remains unclear.
Erythrocyte invasion by the malaria merozoite is a multistep process, initiated by reversible binding to the erythrocyte surface, followed by the establishment of a tight junction between the apical end of the merozoite and erythrocyte surface and the subsequent movement of the merozoite into the nascent parasitophorous vacuole. Each step involves specific interactions between parasite ligands and erythrocyte receptors. Among the ligands of malaria parasites, the best characterized is a type I integral transmembrane protein encoded by the ebl (erythrocyte-binding-like) gene family. Upon release from the micronemes, EBL proteins recognize erythrocyte receptors and initiate the formation of the tight junction.
The importance of EBL in malaria virulence is exemplified in the human malaria parasite Plasmodium vivax which uses an EBL ortholog, PvDBP, to recognize the Duffy antigen on the erythrocyte surface. As the parasite is apparently unable to utilize an alternative invasion pathway, individuals in whom the Duffy antigen is not expressed on the erythrocyte surface are completely resistant to P. vivax (4, 5) . Due to this dramatic association between the disruption of a host-pathogen interaction and protection against a malaria parasite, PvDBP and the Plasmodium falciparum EBL ortholog, EBA-175, have been targeted for vaccine development (6) .
EBL proteins possess two Cys-rich regions conserved among EBL orthologs. The N-terminal Cys-rich region named the DBL (Duffy-Binding-Like) domain or Region 2 (7) recognizes a specific erythrocyte surface receptor. The C-terminal Cys-rich region named the C-cys domain or Region 6 is located adjacent to the transmembrane domain and the number and location of Cys residues are well conserved among known Plasmodium species. Region 6 exhibits structural similarity to the KIX-binding domain of the coactivator CREB-binding protein (8) and has been proposed to be a protein trafficking signal for transportation to the micronemes (9) . Here we report a single non-synonymous nucleotide substitution in the pyebl gene between lethal and non-lethal lines of P. yoelii and show the effect of this substitution on the intracellular localization of EBL, erythrocyte-type preference and consequently virulence of P. yoelii.
Results
In order to investigate differences in EBL between lethal and non-lethal P. yoelii lines, we compared sequences from a variety of malaria parasite species and P. yoelii lines 17X, 17XL, and YM. We found one non-synonymous nucleotide substitution in Region 6 between non-lethal 17X and lethal 17XL lines in the entire open reading frame (Fig. 1) . The non-lethal 17X line possesses 8 conserved Cys residues that form 4 disulfide bridges (8) , whereas the lethal 17XL line possesses an Arg instead of Cys at the second Cys position. This substitution was also found in another lethal line "YM" (2) , which originated independently from the 17X line during serial passage (3) . All Plasmodium EBL orthologs for which protein expression was validated possess 8 conserved Cys residues in this region, further indicating that these Cys residues play an important role ( Fig. S1 ). Thus the observed substitution from Cys to Arg is likely to abolish the native conformation of Region 6.
EBL localizes in the dense granules in P. yoelii line 17XL. We raised specific polyclonal and monoclonal antibodies against PyEBL and performed Western blot analysis. The PyEBL protein was detected as a 110-kDa band in both the 17X and 17XL lines ( Fig. 2A) . The intracellular localization of PyEBL in both the 17X and 17XL lines was compared by indirect immunofluorescent assay (IFA) using specific antibodies against PyEBL (Fig.  S2 ). In the 17X line, PyEBL localized to the apical end of each merozoite in both the segmented schizont-stage parasite and individual merozoites where it colocalized with AMA1, a known microneme protein, under immunofluorescent microscopy ( Fig. 2B ). However, in the 17XL line PyEBL did not colocalize with AMA1 at the apical end of merozoites and showed a more diffused but granular distribution in comparison with parasites of the 17X line ( Fig. 2B ). Diffused localization of PyEBL was also observed in parasites of the YM line ( Fig. S3 ). Immunoelectron microscopy revealed that PyEBL localized in micronemes in the 17X line as reported for P. falciparum and Plasmodium knowlesi (9, 10) . In the 17XL line, however, PyEBL localized not in the microneme, but in another microorganelle -the dense granules (12) (Fig.  2C, Fig. S4 ).
Since there appears to be only one copy of PyEBL in the genomes of both lines ( Fig. S5 ) and significant differences were not observed in the level of transcription and protein expression between the 17X and 17XL lines ( Fig. 2A, Fig. S6 ), the location of EBL appears to be the most significant difference between them.
Genetic replacement of Arg and Cys in Region 6 alters EBL localization.
To evaluate if the Arg substitution at the second Cys position is responsible for the altered trafficking of PyEBL, we exchanged Cys and Arg in the 17X and 17XL lines by genetic modification (17X-CtoR and 17XL-RtoC). The parasites were also transfected with control constructs which do not alter the Region 6 amino acid sequence (17X-CtoC and 17XL-RtoR) ( Fig. 3A) . Each of the transgenic parasites were evaluated for the correct integration of the constructs to the pyebl gene locus by specific PCR analysis followed by sequencing of the PCR-amplified products (not shown) and Southern blot analysis ( Fig. 3B ).
In the 17X line, replacement of Cys with Arg (17X-CtoR) altered the PyEBL localization from an apical pattern to a non-apical diffused pattern and PyEBL did not colocalize with AMA1. Furthermore, the replacement of Arg with Cys in the 17XL line (17XL-RtoC) altered the PyEBL localization from a non-apical diffused pattern to an apical pattern. Control parasites did not display altered PyEBL localization ( Fig. 4) . These results confirm that the observed substitution from Cys to Arg is responsible for the altered localization of PyEBL from micronemes to dense granules in the 17XL line.
EBL localization alters erythrocyte-type preference and course of infection.
In order to determine if altered localization of PyEBL affects erythrocyte-type invasion preference, infected erythrocytes were examined by microscopy and a selectivity index (SI) was obtained by calculating multiple parasite infection of single erythrocytes for each parasite line on day 3 post-infection in mice (13) . We found that 17XL-RtoC predominantly invaded reticulocytes in the same way as the non-lethal 17X line. The SI of the 17XL line (2.38) was increased in 17XL-RtoC (~35; P < 0.001). On the other hand, 17X-CtoR was able to invade a variety of ages of erythrocytes including mature erythrocytes, comparable to the lethal 17XL line, with the SI of the 17X line (16.78) reduced in 17X-CtoR (~4; P < 0.001; Table. 1). These results demonstrate that the localization of PyEBL is responsible for the erythrocyte-type preference of the parasite.
As erythrocyte-type preference frequently correlates with virulence in malaria parasites, we further analyzed the transgenic P. yoelii parasites for differences in the course of infection and survival of parasite-infected mice. Mice infected with the 17XL-RtoC line developed significantly lower parasitemias compared with the parental 17XL and control 17XL-RtoR lines ( Fig. 5A ) with 100% survival (Fig. 5C ), whereas all mice infected with 17XL and 17XL-RtoR lines died by day 7 (Fig. 5C ). The pattern observed for the 17XL-RtoC line was identical to that observed for the non-lethal 17X line. Thus, trafficking of PyEBL to the micronemes causes the virulence of the 17XL line to be reduced to the same level as the non-lethal 17X line, suggesting that PyEBL is a critical virulence determinant in the 17XL line. The parasitemia of mice infected with 17X-CtoR increased significantly compared to those infected with parental 17X and control 17X-CtoC lines during the acute phase of infection on days 4 to 5 (P < 0.001). However, the parasitemia did not reach the level observed for the lethal 17XL line, and reduced to the same level observed for the 17X and 17X-CtoC lines by day 9 (Fig. 5B ). No parasites were detectable by microscopy at day 17 (not shown). This suggests that the 17X-CtoR line is able to invade a greater repertoire of erythrocyte types than 17X, but is unable to invade as many types as the 17XL line. This reduced capacity to invade multiple erythrocyte types compared to the 17XL line results in a non-lethal infection, in which all mice survive ( Fig. 5C ). Thus, displacement of the EBL from microneme was not sufficient to make this line fully lethal, suggesting the existence of other determinant(s).
Discussion
Otsuki et al. -3- The results of this study indicate that replacement of Cys to Arg at the second Cys position of PyEBL Region 6 is the major determinant of the difference between lethal and non-lethal lines of P. y. yoelii parasites. This substitution alters the intracellular organelle localization of PyEBL from the micronemes to the dense granules, and alters the erythrocyte-type invasion preference, course of infection and parasite virulence in the host.
The crystal structure of Region 6 of P. falciparum EBA-175 indicates that the second Cys residue forms a disulfide bridge with the fourth Cys residue in this region. Arg substitution of the second Cys residue in the P. yoelii 17XL line abolishes this disulfide bridge, and thus likely destroys the Region 6 structure which is critical for the trafficking of the protein to the micronemes. It is possible that incorrectly folded Region 6 would not allow the protein to be properly recognized by an (as yet uncharacterized) partner molecule responsible for the trafficking of the EBL protein to the micronemes (9). The mechanism involved in the trafficking of the mutated protein to the dense granules remains unresolved.
Using genetic modification, we have demonstrated that when PyEBL is trafficked to the microneme in the 17XL line genetic background, the erythrocyte-type invasion preference and the course of infection are comparable with those of the non-lethal 17X line. This indicates that the substitution of Cys to Arg is a major determinant of the lethal phenotype of the 17XL line. However, when PyEBL was not trafficked to the microneme in parasites with the 17X line genetic background, the course of infection was intermediate between the two parental lines, suggesting that although PyEBL is a critical determinant, other factor(s) are also involved in the lethal phenotype of the 17XL line. In P. falciparum, the expression of EBL appears to be co-operationally regulated with another Plasmodium ligand encoded by the rbl (reticulocyte-binding-like) multigene family that is composed of 6 members in P. falciparum and at least 14 members in P. yoelii (14 -16) , thus the P. yoelii rbl protein, Py235, is a potential candidate for such factor(s). Consistent with this hypothesis is the finding that when Py235 expression was suppressed, the course of infection of the lethal P. yoelii YM line was altered from a lethal pattern to an intermediate pattern similar to that observed in the 17X-CtoR line shown in this study (17) . Based on these observations, we propose that PyEBL may preferentially recognize reticulocytes and that the removal of PyEBL from the micronemes may result in free space within this organelle that may subsequently be filled with other ligand(s), possibly Py235, which consequently enables the parasite to invade a variety of erythrocyte types. As different Py235 proteins may have different receptor-specificities, parasite invasion preference and the subsequent course of infection may vary, depending on the Py235 member that fills the free space in the micronemes created by the absence of PyEBL. Such a switching mechanism for an erythrocyte invasion pathway has been previously proposed for P. falciparum (18) .
A Linkage Group Selection analysis conducted by Pattaradilokrat et al [submitted together with this manuscript] identified a chromosomal region which included the ebl gene locus as a major determinant in the multiplication rate differences between the lethal P. y.
yoelii YM line and a non-lethal 33X line, supporting the role of the EBL protein in controlling virulence phenotypes. Consistent with our findings that another genetic factor may be involved, they also identified a further genomic region on P. yoelii chromosome 5 or 6 that showed weak association with multiplication rate.
As PyEBL localized in the dense granules is potentially non-functional, we attempted to disrupt the pyebl gene locus in both the 17X and 17XL lines ( Fig. S7 ). However, repeated attempts failed to achieve this, despite the successful genomic integration of the control plasmid. This indicates PyEBL is essential for parasite survival even when it is not trafficked to the microneme. Two possible explanations for this may be; an undetectable amount of PyEBL may still localize in the micronemes and remain functional, or PyEBL is functional during erythrocyte invasion (or for another unknown critical role during the life cycle) even when localized in the dense granules. Although a subgroup of the dense granules, known as exonemes, were recently reported to secrete their contents immediately prior to schizont rupture (19) , we found that PyEBL was not detected on the surface of released individual merozoites of 17XL parasites ( Fig. S8) . Thus, the identity of the PyEBL-containing dense granules and the timing of PyEBL secretion from them, if at all, in the 17XL line remain undetermined.
In summary, we have found that a single nucleotide substitution altered the intracellular localization of the malaria parasite ligand PyEBL, which in turn altered erythrocyte invasion preference, course of infection, and parasite virulence. The virulence-mediating mechanism described in this report furthers our understanding of parasite-host interactions, and has important implications for malaria vaccine design especially those based on PvDBP for P. vivax malaria.
Materials and Methods
Rodent malaria parasites. Plasmodium yoelii 17X, 17XL, and YM lines were maintained in BALB/c mice (Charles River Japan Inc., Japan). P. yoelii YM line was a kind gift from David Walliker, Edinburgh University, UK.
DNA and RNA isolation. Parasite genomic DNA (gDNA) was isolated from parasite-infected mouse blood using DNAzol BD reagent (Invitrogen, Carlsbad, CA). Parasite-infected blood was passed through one CF11 cellulose column to remove leukocytes and a schizont-enriched fraction was collected by differential centrifugation on a 50% Percoll™ solution (GE Healthcare, Buckinghamshire, UK). Total RNA was isolated from the schizont-enriched fraction using RNeasy Mini Kit (QIAGEN, Germany). Complementary DNA (cDNA) was synthesized using Omniscript reverse transcriptase (QIAGEN) with random hexamer after DNAse treatment.
PCR amplification and sequencing of ebl genes. ebl genes were PCR-amplified from gDNA using KOD Plus DNA polymerase (TOYOBO, Japan) with specific primers for each ebl gene designed using the P. yoelii genome database (The Institute for Genomic Research website) and the P. chabaudi and P. berghei genome project' databases (The Sanger Centre website). ebl sequences were determined by direct sequencing using an ABI PRISM® 310 genetic analyzer (Applied Biosystems, Foster City, Otsuki et al. -4-CA) from PCR-amplified products. Sequences were aligned in CLUSTALW implemented in MacVector (ver. 9.0; Accelrys, Inc., San Diego, CA).
Southern blot analysis.
Five micrograms of P. yoelii gDNA were digested with EcoRI, EcoRV, ClaI, BanI and NspI, and BanI and HpaI with appropriate buffer overnight. Digested gDNA was subjected to electrophoresis on 0.8% agarose gels, followed by alkaline transfer onto a Hybond-N+ PVDF membrane (GE Healthcare). Probes were firstly PCR-amplified with 5'-TAAATCTAAATGGGATACAT-3' and 5'-AGTTGGATTGATAGTTACAGATTC-3' primers for the pyebl region (Pr), cloned into pGEM-T Easy® plasmid (Promega, Madison, WI), digested from the plasmid, and then hybridized onto membranes. Probes were labeled with the AlkPhos Direct kit (GE Healthcare) and a chemi-luminescenct signal developed with CDP-star reagent (GE Healthcare) was recorded on RX-U film (FUJI-FILM, Japan).
Recombinant proteins.
Expression plasmids were constructed based on the pEU-E01-G(TEV)-N2 vector (20) by inserting PCR products amplified from P. yoelii 17X gDNA using KOD Plus DNA polymerase with following primers: 5'-gagaCTCGAGGTTAATTTATTAAAAAGAACATAT GAATCTTTCC-3' and 5'-tctcGGATCCCTATGAATAGCTCTCTTTTTGAAAA C-3' for PyEBL regions 1 to 6 (R1-6; amino acid positions 28 -787), 5'-gagaCTCGAGGTTAATTTATTAAAAAGAACATAT GAATCTTTCC-3' and 5'-tctcGGATCCCTACAAATTATTATTAATAGGAGT ATTACTGGG-3' for regions 1 to 2 (R1-2; 28 -436), 5'-gagaCTCGAGGAAAAAAATGGAAATGTAAATTA CAAAG-3' and 5'-tctcGGATCCCTACAAATTATTATTAATAGGAGT ATTACTGGG-3' for region 2 (R2; 113 -436), 5'-gagaCTCGAGTCTTCTGTTAAACCCAGTAATAC-3 ' and 5'-tctcGGATCCCTATACATTTTCGTTGGCTAGC-3' for regions 3 to 5 (R3-5; 423 -716), and 5'-GAGAGAGACTCGAGGACCCTAAACATGTATGT GTTGATAC-3' and 5'-GAGAGAGAGGATCCTCATCCCATAAAGCTGGA AGAACTACAG-3' for the 19-kDa region of the merozoite surface protein 1, PyMSP1 (PyMSP1-19; 1658 -1757). The stop codon is shown in bold letters and XhoI and BamHI restriction sites are underlined. Glutathione S-transferase (GST)-fused PyEBL or PyMSP1-19 recombinant proteins were expressed using the wheat germ cell free protein synthesis system (Protemist DT, CellFree Sciences, Matsuyama, Japan). Recombinant proteins were captured by a glutathione column, washed, and eluted with glutathione elution buffer. Protein synthesis was confirmed by SDS-PAGE and Coomassie Brilliant Blue protein staining. Recombinant PyEBL R1-6 and R3-5 and PyMSP1-19 were used to produce antibodies and PyEBL R1-2, and R2 were used for Western blot analysis.
Antibodies.
To produce mouse anti-PyEBL and anti-PyMSP1 sera, female BALB/c mice were intraperitoneally immunized 5 times with recombinant PyEBL R1-6 or 3 times with recombinant PyMSP1-19 emulsified with Freund's adjuvant, and sacrificed for serum collection. To produce rabbit anti-PyEBL R3-5 serum, a female Japanese white rabbit was subcutaneously immunized 3 times with recombinant PyEBL R3-5 emulsified with Freund's adjuvant. To produce mouse anti-PyEBL monoclonal antibodies, the spleen was removed from a mouse immunized with recombinant PyEBL R1-6 and spleen cells were fused with a mouse myeloma cell line derived from a BALB/c mouse by conventional polyethylene glycol method. Supernatants of cultured hybridoma colonies were tested with recombinant PyEBL R1-6 by enzyme-linked immunosorbent assay and on P. yoelii 17 X blood smears by indirect immunofluorescent assay. Positive hybridoma colonies were selected and cloned by two rounds of limiting dilution. The epitope region of each monoclonal antibody was tested by Western blot with a panel of recombinant PyEBL proteins. Anti-AMA1 rabbit serum was a gift from Carole Long, National Institutes of Health, USA.
Immunofluorescence microscopy. P. yoelii-infected mouse erythrocytes were smeared onto glass slides, air dried and stored at -80˚C without fixation. Slides were thawed, acetone-fixed, preincubated with PBS containing 5% non-fat milk at 37˚C for 30 min, incubated with mouse anti-PyEBL and rabbit anti-AMA1 sera at room temperature for one hour, and then incubated with fluorescein isothiocyanate (FITC)-conjugated goat anti-(mouse IgG and IgM) antibody (Biosource Int., Camarillo, CA) and Alexa-546 conjugated goat anti-rabbit IgG antibody (Molecular Probes, Eugene, OR) at 37˚C for 30 min. Parasite nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI). Differential interference contrast (DIC) and fluorescent images were obtained using a fluorescence microscope (BX50; Olympus, Japan) with a CCD digital camera (DC500; Leica, Germany), and processed using Adobe Photoshop CS (ver. 8.0; Adobe Systems Inc., San Jose, CA).
Immunoelectron microscopy. P. yoelii-infected mouse blood was fixed in 1% paraformaldehyde-0.1% glutaraldehyde in Hepes-buffered saline, and embedded in LR white resin (Polysciences, Inc., Warrington, PA). Sections were blocked for 30 min in PBS-milk-Tween 20, incubated overnight at 4˚C in PBS-milk-Tween 20 containing mouse anti-PyEBL R1-6 serum, and then incubated for 1 hour in PBS-milk-Tween 20 containing goat anti-mouse IgG conjugated with gold particles (10 nm diameter; Jansen, Piscataway, NJ). Sections were stained with 2% uranyl acetate in 50% methanol and examined by electron microscopy (JEM-1230; JEOL, Japan).
Genetic modification of the pyebl gene locus. Two basic plasmids, pPbDT3U-B12 and pHDEF1-mh-R12, were constructed. A DNA fragment encoding cyan fluorescent protein (CFP) was PCR-amplified from pECFP-C1 plasmid (Stratagene) using KOD Plus DNA polymerase with primers 5'-agcGCTAGCGTGAGCAAGGGCGAG-3' (NheI site is underlined) and 5'-gacGTCGACGGATCCTCTAGACTTGTACAGCTC GTCC-3' (SalI and XbaI sites are underlined and BamHI site is shown in bold), and ligated into the pGEM-T Easy plasmid. The insert was then digested with NheI and SalI, purified, and ligated into pRGDT-B12 (21) using the NheI Otsuki et al. -5- and SalI sites, yielding pRCDT-B12. pRCDT-B12 was digested with ClaI and XbaI and filled with a oligonucleotide linker comprising cgatCTCGAGCCCGGGt and ctagaCCCGGGCTCGAGat to generate XhoI (underlined) and SmaI (bold) sites to yield pPbDT3U-B12. pHDEF1-mh (22) was digested with SmaI and ApaI to remove the 3' untranslated region of histidine rich protein 2, the ApaI cohesive end was blunted and a Gateway gene conversion cassette C1 (Invitrogen) was inserted. The XhoI site was destroyed by XhoI-digestion, filled-in using KOD Plus DNA polymerase, and self-ligated to yield pHDEF1-mh-R12.
To modify the pyebl gene locus, a DNA fragment encoding PyEBL region 6 to the stop codon was PCR-amplified from gDNA of the P. yoelii 17XL line with primers 5'-gCCATGGGAACATAGAGACATTAAAAAAAGC-3 ' and 5'-gCTCGAGATAAAAATCTACAGGTATATATTC-3' (NcoI and XhoI sites are underlined) and cloned into pGEM-T Easy ® plasmids. The insert was ligated into the NcoI and XhoI sites of pPbDT3U-B12 to yield pR6Cyt-B12. DNA fragments encoding PyEBL region 3 to the stop codon were PCR-amplified from cDNA of P. yoelii 17X and 17XL lines with primers 5'-atCTTCTGTTAAACCCAGTAATAC-3' and 5'-ccAGATCTTTAATAAAAATCTACAGGTATATATT C-3' (BglII site is underlined). PCR products were then ligated into the SmaI site of pR6Cyt-B12, yielding pR6Cyt+R3Cyt(X)-B12 and pR6Cyt+R3Cyt(XL)-B12, respectively.
pR6Cyt+R3Cyt(X)-B12 and pR6Cyt+R3Cyt(XL)-B12 were subjected to a BP recombination reaction with the donor vector pDONR™221 (Invitrogen) to produce the corresponding entry plasmids pENT.R6Cyt+R3Cyt(X) and pENT.R6Cyt+R3Cyt(XL). These entry plasmids were subjected to a LR recombination reaction (Invitrogen) according to the manufacturer's instructions with pHDEF-1-mh-R12 to yield replacement constructs pYEBL-R6Cyt+R3Cyt(X) and pYEBL-R6Cyt+R3Cyt(XL), respectively. P. yoelii schizont-enriched fraction was collected by differential centrifugation on 50% HistoDenz in PBS and 20 µg of XhoI-digested transfection constructs were electroporated to 5 × 10 7 of enriched schizonts using the Nucleofector™ device (Amaxa GmbH, Germany) with Human T cell solution under program U-33 (23) . Transfected parasites were intravenously injected into 8-weeks-old BALB/c female mice, which were treated by intraperitoneal injection with 1 mg/kg of pyrimethamine daily. Before inoculation of 17X line parasites, mice were treated with phenylhydrazine to increase the reticulocyte population in the blood. Drug resistant parasites were cloned by limiting dilution. Integration of the transfection constructs was confirmed by PCR-amplification with a unique set of primers for the modified pyebl gene locus followed by sequencing, and Southern blot analysis.
Course of infection.
To assess the course of infection of transgenic and wild type parasite lines, 1 × 10 6 parasitized erythrocytes were injected intravenously into 8-week-old female BALB/c mice. Thin blood smears were made daily, stained with Giemsa's solution, and parasitemias were recorded. Mouse survival was evaluated by the Kaplan-Meier method. Parasitemias of each group were compared by one-way ANOVA test and Tukey's post test implemented in Prism4.0 (GraphPad Software, San Diego, CA).
Selectivity index.
To compare erythrocyte preference between transgenic and wild type P. yoelii parasite lines, a selectivity index was calculated as follows; multiple-infected erythrocytes divided by the expected number of multiple-infected erythrocytes, which was calculated from the number of infected erythrocytes and parasitemia (13) . When the preferred erythrocyte type is limited, the observed number of multiple-infected erythrocytes increases. More than 200 parasitized erythrocytes were examined on Giemsa-stained thin blood smears collected on day 3 post-inoculation. The selectivity index of each group was compared by one-way ANOVA test and Tukey's post test implemented in Prism4.0. yoelii schizonts were incubated with mAb 5B10 (α-EBL), rabbit anti-AMA1 serum (α-AMA1), and DAPI (blue) for nuclear staining. Schizonts labeled with anti-PyEBL (5B10) were stained with FITC secondary antibody (green). Anti-AMA1 were stained with Alexa-546 secondary antibody (red). Differential interference contrast (DIC) images are shown in the right-hand column. 17X line shows apical PyEBL signal co-localized with AMA1, but region 6 substituted 17XL line shows diffused staining that does not co-localize with AMA1. (C) Immunoelectron microcopy was carried out for resin-embedded P. yoelii 17X and 17XL lines with anti-PyEBL mouse serum and secondary antibody conjugated with gold particles. PyEBL was detected in the micronemes (arrowheads) of the 17X line, but in the 17XL line, it was located in the dense granules (arrows). N, Mn, DG and Rh indicate nucleus, microneme, dense granule and rhoptry. Hybridization of pyebl probe detected only a single band from EcoRIor EcoRV-digested DNA and only two bands from BanI/HpaIor BanI/NspI-digested DNA. If the P. yoelii genome possesses more than a single copy of pyebl, additional bands are likely to be observed. Taken together with the fact that only a single copy of the pyebl gene can be found in the P. yoelii (17X line) genome database (5-fold coverage), this result strongly suggests that pyebl is a single copy gene in both the 17X and 17XL lines. Schematic of the wild-type (WT) and knock-out (KO) pyebl gene loci. The knock-out cassette (Insert) would be inserted into the pyebl gene locus by double crossover recombination and disrupts gene function. A total of 4 attempts to disrupt the pyebl gene locus were performed in 17X and 17XL lines (twice for each) without success. As a control, replacement plasmids, pYEBL-R6Cyt+R3Cyt(X) and pYEBL-R6Cyt+R3Cyt(XL), were simultaneously transfected and genomic integration of these plasmids was always obtained. Figure S8 . PyEBL was not expressed on the released merozoite surface. Live merozoites of P. yoelii 17X and 17XL lines were incubated with rabbit anti-PyEBL R3-5 serum (α-EBL) and mouse anti-PyMSP1-19 serum (α-MSP1), followed by secondary antibodies conjugated with fluorescent Alexa dyes and DAPI for nuclear staining. Differential interference contrast (DIC) images are shown in the right-hand column. MSP1 was detected on the merozoite surface, but EBL was not. Anti-PyMSP1-19 serum was produced by N. Kangwanrangsan, Ehime University.
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